Follow
Mruniya Gawali
Mruniya Gawali
Verified email at ccf.org
Title
Cited by
Cited by
Year
AMPK-regulated astrocytic lactate shuttle plays a non-cell-autonomous role in neuronal survival
R Muraleedharan, MV Gawali, D Tiwari, A Sukumaran, N Oatman, ...
Cell reports 32 (9), 2020
752020
Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma
K Golan, AK Singh, O Kollet, M Bertagna, MJ Althoff, E Khatib-Massalha, ...
Blood, The Journal of the American Society of Hematology 136 (23), 2607-2619, 2020
562020
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer
N Oatman, N Dasgupta, P Arora, K Choi, MV Gawali, N Gupta, ...
Science Advances 7 (7), eabd7459, 2021
442021
Neuroprotective effect of Cubebin: A dibenzylbutyrolactone lignan on scopolamine-induced amnesia in mice
GS Somani, MS Nahire, AD Parikh, MB Mulik, PJ Ghumatkar, KS Laddha, ...
Indian journal of medical research 146 (2), 255-259, 2017
202017
Screening of Pistacia integerrima extracts for their anticonvulsant activity in acute zebrafish and rodent models of epilepsy
PD Jain, RM Tambe, JS Sancheti, MS Nahire, AK Bhardwaj, S Sathaye
International Journal of Nutrition, Pharmacology, Neurological Diseases 5 (2 …, 2015
182015
Brain pharmacokinetics and metabolism of the AMP-activated protein kinase selective inhibitor SBI-0206965, an investigational agent for the treatment of glioblastoma
JM Desai, AS Karve, GA Gudelsky, MV Gawali, W Seibel, L Sallans, ...
Investigational new drugs 40 (5), 944-952, 2022
42022
EXTH-52. SYSTEMIC AND BRAIN PHARMACOKINETICS OF THE AMP-ACTIVATED PROTEIN KINASE SELECTIVE INHIBITOR SBI-0206965 AS A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF …
J Desai, M Gawali, A Karve, G Gudelsky, L Sallans, B Dasgupta, W Seibel, ...
Neuro-Oncology 23 (Supplement_6), vi175-vi175, 2021
2021
SYSTEMIC AND BRAIN PHARMACOKINETICS OF THE AMP-ACTIVATED PROTEIN KINASE SELECTIVE INHIBITOR SBI-0206965 AS A POTENTIAL THERAPEUTIC AGENT FOR THE TREATMENT OF GLIOBLASTOMA …
J Desai, M Gawali, A Karve, G Gudelsky, L Sallans, B Dasgupta, W Seibel, ...
NEURO-ONCOLOGY 23, 175-175, 2021
2021
CBMT-05. GENETIC AND EPIGENETIC MECHANISMS REGULATING SCD INHIBITOR SENSITIVITY IN GLIOBLASTOMA
N Oatman, N Dasgupta, B Dasgupta, K Choi, M Gawali, N Gupta, ...
Neuro-Oncology 21 (Suppl 6), vi33, 2019
2019
Neuroprotective Effects of Cubebin On Scopolamine-Induced Amnesia Via Anti-Acetylcholinesterase and Anti-Oxidative Activities in Mice
MS Nahire, GS Somani, AD Parikh, MB Mulik, PJ Ghumatkar, KS Laddha, ...
INDIAN JOURNAL OF PHARMACOLOGY 45, S100-S100, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–10